115 related articles for article (PubMed ID: 7810170)
1. Metabolism of 1,1-dichloro-2,2,2-trifluoroethane in rats.
Urban G; Dekant W
Xenobiotica; 1994 Sep; 24(9):881-92. PubMed ID: 7810170
[TBL] [Abstract][Full Text] [Related]
2. The role of cytochrome P450 2E1 in the species-dependent biotransformation of 1,2-dichloro-1,1,2-trifluoroethane in rats and mice.
Dekant W; Assmann M; Urban G
Toxicol Appl Pharmacol; 1995 Dec; 135(2):200-7. PubMed ID: 8545828
[TBL] [Abstract][Full Text] [Related]
3. Pentahaloethane-based chlorofluorocarbon substitutes and halothane: correlation of in vivo hepatic protein trifluoroacetylation and urinary trifluoroacetic acid excretion with calculated enthalpies of activation.
Harris JW; Jones JP; Martin JL; LaRosa AC; Olson MJ; Pohl LR; Anders MW
Chem Res Toxicol; 1992; 5(5):720-5. PubMed ID: 1446014
[TBL] [Abstract][Full Text] [Related]
4. Biotransformation and hepatotoxicity of HCFC-123 in the guinea pig: potentiation of hepatic injury by prior glutathione depletion.
Lind RC; Gandolfi AJ; Hall PD
Toxicol Appl Pharmacol; 1995 Sep; 134(1):175-81. PubMed ID: 7676453
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 1,2-dichloro-1-fluoroethane and 1-fluoro-1,2,2-trichloroethane: electronic factors govern the regioselectivity of cytochrome P450-dependent oxidation.
Yin H; Anders MW; Jones JP
Chem Res Toxicol; 1996; 9(1):50-7. PubMed ID: 8924616
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 inactivation during reductive metabolism of 1,1-dichloro-2,2,2-trifluoroethane (HCFC-123) by phenobarbital- and pyridine-induced rat liver microsomes.
Ferrara R; Tolando R; King LJ; Manno M
Toxicol Appl Pharmacol; 1997 Apr; 143(2):420-8. PubMed ID: 9144458
[TBL] [Abstract][Full Text] [Related]
7. Investigations on the liver toxicity of a blend of HCFC-123 (2,2-dichloro-1,1,1-trifluoroethane) and HCFC-124 (2-chloro-1,1,1,2-tetrafluoroethane) in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Nomiyama T; Rahier J; Lison D
Arch Toxicol; 2001 Jul; 75(5):274-83. PubMed ID: 11548120
[TBL] [Abstract][Full Text] [Related]
8. Metabolism of 1-fluoro-1,1,2-trichloroethane, 1,2-dichloro-1,1-difluoroethane, and 1,1,1-trifluoro-2-chloroethane.
Yin H; Jones JP; Anders MW
Chem Res Toxicol; 1995 Mar; 8(2):262-8. PubMed ID: 7766810
[TBL] [Abstract][Full Text] [Related]
9. Potentiation of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123)-induced liver toxicity by ethanol in guinea-pigs.
Hoet P; Buchet JP; Sempoux C; Haufroid V; Rahier J; Lison D
Arch Toxicol; 2002 Dec; 76(12):707-14. PubMed ID: 12451447
[TBL] [Abstract][Full Text] [Related]
10. Gas-uptake pharmacokinetics of 2,2-dichloro-1,1,1-trifluoroethane (HCFC-123).
Loizou GD; Urban G; Dekant W; Anders MW
Drug Metab Dispos; 1994; 22(4):511-7. PubMed ID: 7956723
[TBL] [Abstract][Full Text] [Related]
11. Biotransformation of 2,3,3,3-tetrafluoropropene (HFO-1234yf).
Schuster P; Bertermann R; Snow TA; Han X; Rusch GM; Jepson GW; Dekant W
Toxicol Appl Pharmacol; 2008 Dec; 233(2):323-32. PubMed ID: 18817801
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of 1,1-dichloro-1-fluoroethane (HCFC-141b) in human volunteers.
Tong Z; Utell MJ; Morrow PE; Rusch GM; Anders MW
Drug Metab Dispos; 1998 Jul; 26(7):711-3. PubMed ID: 9660855
[TBL] [Abstract][Full Text] [Related]
13. Metabolism of the chlorofluorocarbon substitute 1,1-dichloro-2,2,2-trifluoroethane by rat and human liver microsomes: the role of cytochrome P450 2E1.
Urban G; Speerschneider P; Dekant W
Chem Res Toxicol; 1994; 7(2):170-6. PubMed ID: 8199305
[TBL] [Abstract][Full Text] [Related]
14. Dose-dependent metabolism of 2,2-dichloro-1,1,1-trifluoroethane: a physiologically based pharmacokinetic model in the male Fischer 344 rat.
Vinegar A; Williams RJ; Fisher JW; McDougal JN
Toxicol Appl Pharmacol; 1994 Nov; 129(1):103-13. PubMed ID: 7974482
[TBL] [Abstract][Full Text] [Related]
15. Gas-uptake pharmacokinetics and biotransformation of 1,1-dichloro-1-fluoroethane (HCFC-141b).
Loizou GD; Anders MW
Drug Metab Dispos; 1993; 21(4):634-9. PubMed ID: 8104122
[TBL] [Abstract][Full Text] [Related]
16. Biotransformation of trans-1,1,1,3-tetrafluoropropene (HFO-1234ze).
Schuster P; Bertermann R; Rusch GM; Dekant W
Toxicol Appl Pharmacol; 2009 Sep; 239(3):215-23. PubMed ID: 19573548
[TBL] [Abstract][Full Text] [Related]
17. Toxicology of chlorofluorocarbon replacements.
Dekant W
Environ Health Perspect; 1996 Mar; 104 Suppl 1(Suppl 1):75-83. PubMed ID: 8722112
[TBL] [Abstract][Full Text] [Related]
18. The kidney as a novel target tissue for protein adduct formation associated with metabolism of halothane and the candidate chlorofluorocarbon replacement 2,2-dichloro-1,1,1-trifluoroethane.
Huwyler J; Aeschlimann D; Christen U; Gut J
Eur J Biochem; 1992 Jul; 207(1):229-38. PubMed ID: 1628651
[TBL] [Abstract][Full Text] [Related]
19. Metabolism and pharmacokinetics of selected halon replacement candidates.
Dodd DE; Brashear WT; Vinegar A
Toxicol Lett; 1993 May; 68(1-2):37-47. PubMed ID: 8516773
[TBL] [Abstract][Full Text] [Related]
20. Metabolism of 14C-dichloroethyne in rats.
Kanhai W; Koob M; Dekant W; Henschler D
Xenobiotica; 1991 Jul; 21(7):905-16. PubMed ID: 1776266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
